Skip to main content

Advertisement

Log in

Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To determine if obesity is associated with poorer patient-reported outcomes (PROs) in patients with axial spondyloarthritis (axSpA), we conducted a cross-sectional study using data of the PRESPOND registry from a tertiary referral center in Singapore between 2011 and 2015. Demographics, clinical, and PRO variables were collected. Patients were divided into three categories: normal (BMI < 23 kg/m2), overweight (23 kg/m2 ≤ BMI < 27.5 kg/m2) and obese (BMI ≥ 27.5 kg/m2), using Asian BMI classification. The dependent variables are Pain score, Bath Ankylosing Spondylitis Patient Global Score (BAS-G), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Health Assessment Questionnaire (HAQ), and Medical Outcomes Study Short Form 36 version 2 (SF-36). Multivariate regression analyses were performed with these dependent variables and obesity categories, adjusting for confounders. Among 194 patients with axSpA, 32% are overweight while 22% are obese. We found that obese patients had significant poorer pain (β: 11.87, 95%CI 2.13, 21.60) and BAS-G scores (β: 10.18, 95%CI 1.59, 18.76) when compared to normal BMI patients. However, obesity was not associated with BASDAI (β 0.50, 95%CI -0.22, 1.22), BASFI (β 0.08, 95%CI -0.66, 0.81), HAQ (β -0.07, 95%CI -0.21, 0.06), physical component summary (β -0.02, 95%CI -4.47, 4.44), and mental component summary (β -2.85, 95%CI -7.57, 1.88) of SF-36. Obesity was associated with pain score and BAS-G but not with BASDAI, BASFI, HAQ, and SF-36. Further study is needed to examine the causal relationship between obesity and poorer PROs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Spondyloarthritis. Arthritis Foundation. http://www.arthritis.org/about-arthritis/types/spondyloarthritis/Accessed 3 Sept 2016

  2. Stolwijk C, Boonen A, van Tubergen A, Reveille JD (2012) Epidemiology of spondyloarthritis. Rheum Dis Clin N Am 38(3):441–476. doi:10.1016/j.rdc.2012.09.003

    Article  Google Scholar 

  3. Obesity and Overweight. World Health Organization. http://www.who.int/mediacentre/factsheets/fs311/en/ Accessed 3 Sept 2016

  4. WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London, England) 363(9403):157–63. DOI: 10.1016/S0140-6736(03)15268-3

  5. Khaodhiar L, McCowen KC, Blackburn GL (1999) Obesity and its comorbid conditions. Clinical cornerstone 2(3):17–31. doi:10.1016/S1098-3597(99)90002-9

    Article  CAS  PubMed  Google Scholar 

  6. Durcan L, Wilson F, Conway R, Cunnane G, O’Shea FD (2012) Increased body mass index in ankylosing spondylitis is associated with greater burden of symptoms and poor perceptions of the benefits of exercise. J Rheumatol 39(12):2310–2314. doi:10.3899/jrheum.120595

    Article  PubMed  Google Scholar 

  7. Rubio Vargas R, van den Berg R, van Lunteren M, Ez-Zaitouni Z, Bakker PAC, Dagfinrud H et al (2016) Does body mass index (BMI) influence the ankylosing spondylitis disease activity score in axial spondyloarthritis? Data from the SPACE cohort: RMD Open 2(1):e000283. doi:10.1136/rmdopen-2016-000283

    PubMed  PubMed Central  Google Scholar 

  8. The Bath Indices. National Ankylosing Spondylitis Society. nass.co.uk/download/4c4da6b17854b/ Accessed on 10 Sept 2016

  9. The Healthcare Assessment Questionnaire. National Institute of Environmental Health Sciences. https://www.niehs.nih.gov/research/resources/assets/docs/haq_instructions_508.pdf Accessed on 12 Sept 2016

  10. Wang R, Wu C, Zhao Y, Yan X, Ma X, Wu M et al (2008) Health related quality of life measured by SF-36: a population-based study in Shanghai, China. BMC Public Health 8:292. doi:10.1186/1471-2458-8-292

    Article  PubMed  PubMed Central  Google Scholar 

  11. Moncur C (2003) Ankylosing spondylitis measures: the ankylosing spondylitis quality of life (ASQOL) scale, bath ankylosing spondylitis disease activity index (BASDAI), bath ankylosing spondylitis functional index (BASFI), bath ankylosing spondylitis global score (BAS-G), bath ankylosing spondylitis metrology index (BASMI), Dougados functional index (DFI), health assessment questionnaire for the spondyloarthropathies (HAQ-S), and revised Leeds disability questionnaire (RLDQ). Arthritis care & research 49(S5):S197–S209. doi:10.1002/art.11412

    Article  Google Scholar 

  12. Kwan YH, Fong W, Lui NL, Yong ST, Cheung YB, Malhotra R, Thumboo J, Østbye T (2016) Validity and reliability of the health assessment questionnaire among patients with spondyloarthritis in Singapore. Int J Rheum Dis. doi:10.1111/1756-185X.12989

  13. Kwan YH, Fong WWS, Lui NL, Yong ST, Cheung YB, Malhotra R et al (2016) Validity and reliability of the short form 36 health surveys (SF-36) among patients with spondyloarthritis in Singapore. Rheumatol Int:1–7. doi:10.1111/1756-185X.12989

  14. Ware JE, Jr., Gandek B (1998) Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 51(11):903–12.

  15. Medical Outcomes Scale SF-36. American Psychological Association. http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/medical-outcomes.aspx Accessed one 14 Sept 2016

  16. Maas F, Arends S, van der Veer E, Wink F, Efde M, Bootsma H et al (2016) Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome. J Rheumatol 43(2):383–387. doi:10.3899/jrheum.150648

    Article  CAS  PubMed  Google Scholar 

  17. Oh SW, Shin S-A, Yun YH, Yoo T, Huh B-Y (2004) Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res 12(12):2031–2040. doi:10.1038/oby.2004.254

    Article  PubMed  Google Scholar 

  18. Gremese E, Tolusso B, Gigante MR, Ferraccioli G. (2014) Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Frontiers in Immunology 5. DOI: 10.3389/fimmu.2014.00576

  19. Kane A How fat affects arthritis. Arthritis Foundation. http://www.arthritis.org/living-with-arthritis/comorbidities/obesity-arthritis/fat-and-arthritis.php Accessed on 14 Sept 2016

  20. Fabre S, Molto A, Dadoun S, Rein C, Hudry C, Kreis S et al (2016) Physical activity in patients with axial spondyloarthritis: a cross-sectional study of 203 patients. Rheumatol Int 36(12):1711–1718. doi:10.1007/s00296-016-3565-5

    Article  PubMed  Google Scholar 

  21. McVinnie DS (2013) Obesity and pain. British Journal of Pain 7(4):163–170. doi:10.1177/2049463713484296

    Article  PubMed  PubMed Central  Google Scholar 

  22. Okifuji A, Hare BD (2015) The association between chronic pain and obesity. J Pain Res 8:399–408. doi:10.2147/JPR.S55598

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wendling D, Prati C (2016) Spondyloarthritis and fibromyalgia: interfering association or differential diagnosis? Clin Rheumatol 35(9):2141–2143. doi:10.1007/s10067-016-3353-3

    Article  PubMed  Google Scholar 

  24. Wach J, Letroublon MC, Coury F, Tebib JG (2016) Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol 43(11):2056–2063. doi:10.3899/jrheum.160104

    Article  PubMed  Google Scholar 

  25. Bello N, Etcheto A, Béal C, Dougados M, Moltó A. (2016) Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis research & therapy 18. DOI: 10.1186/s13075-016-0943-z

  26. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5):600–610. doi:10.1002/acr.20140

    Article  Google Scholar 

  27. Ni C, Chiu MW (2014) Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol 7:119–132. doi:10.2147/CCID.S44843

    PubMed  PubMed Central  Google Scholar 

  28. Why use BMI? Harvard School of Public Health. https://www.hsph.harvard.edu/obesity-prevention-source/obesity-definition/obesity-definition-full-story/ Accessed on 15 Sept 2016

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Warren Fong.

Ethics declarations

Disclosure

None.

Additional information

Yi Xuan Lee and Yu Heng Kwan contributed equally to this work.

Electronic supplementary material

Supplementary Tables

(DOCX 62.5 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, Y.X., Kwan, Y.H., Png, W.Y. et al. Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population. Clin Rheumatol 36, 2365–2370 (2017). https://doi.org/10.1007/s10067-017-3585-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3585-x

Keywords

Navigation